A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease (Q37284534)
Jump to navigation
Jump to search
scientific article published on 20 May 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease |
scientific article published on 20 May 2009 |
Statements
1 reference
A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease (English)
1 reference
C Keywood
1 reference
M Wakefield
1 reference
J Tack
1 reference
20 May 2009
1 reference
1192-1199
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference